Future in vivo studies using myocardial infarction animal models are therefore essential to confirm whether Quercetin truly exerts cardioprotective effects by modulating VEGFA, PTK2, and GGT1, as predicted in our bioinformatic and molecular docking analyses. This evidence concerns the gene PTK2 and myocardial infarction.